title: Prior statin use reduces mortality in intracerebral hemorrhage.
abstract: OBJECTIVE
  To assess the impact of blood glucose, coagulopathy, seizures and prior statin and aspirin use on clinical outcome following intracerebral hemorrhage (ICH).
  
  
  BACKGROUND
  Intracerebral hemorrhage (ICH) accounts for 10-15% of all strokes with mortality rates approaching 50%. Glasgow Coma Scale (GCS), ICH volume, age, pulse pressure, ICH location, intraventricular hemorrhage (IVH) and hydrocephalus are known to impact 30-day survival following ICH and are included in various prediction models. The role of other clinical variables in the long-term outcome of these patients is less clear.
  
  
  METHODS
  Records of consecutive ICH patients admitted to The Johns Hopkins Hospital from 1999 to 2006 were reviewed. Patients with ICH related to trauma or underlying lesions (e.g. brain tumors, aneurysms, arterio-venous malformations) and of infratentorial location were excluded. The impact of admission blood glucose, coagulopathy, seizures on presentation and prior statin and aspirin use on 30-day mortality and functional outcomes at discharge was assessed using dichotomized Modified Rankin Scale (dMRS) and Glasgow Outcomes scale (dGOS). Other variables known to impact outcomes that were included in the multiple logistic regression analysis were age, admission GCS, pulse pressure, ICH volume, ICH location, volume of IVH and hydrocephalus.
  
  
  RESULTS
  A total of 314 patients with ICH were identified, 125 met inclusion criteria. Patients' age ranged from 34 to 90 years (mean 63.5), 57.6 % were male. Mean ICH volume was 32.09 cc (range 1-214 cc). Following multiple logistic regression analysis, prior statin use (P = 0.05) was found to be associated with decreased mortality with a greater than 12-fold odds of survival while admission blood glucose (P = 0.023) was associated with increased 30-day mortality. Coagulopathy, seizures on presentation, and prior aspirin use had no significant impact on 30-day mortality or outcomes at discharge in our study cohort.
  
  
  CONCLUSIONS
  The significant association of prior statin use with decreased mortality warrants prospective evaluation of the use of statins following ICH.
authors: The Johns Hopkins Hospital, Baltimore, MD, USA. nnaval1@jhmi.edu
authors: Neeraj S
authors: NS
authors: Naval
authors: Tamer A
authors: TA
authors: Abdelhak
authors: Paloma
authors: P
authors: Zeballos
authors: Nathalie
authors: N
authors: Urrunaga
authors: Marek A
authors: MA
authors: Mirski
authors: Juan R
authors: JR
authors: Carhuapoma
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001778:Blood Coagulation Disorders / Q000401:mortality; D001786:Blood Glucose; D002543:Cerebral Hemorrhage / Q000188:drug therapy* / Q000401:mortality*; D004827:Epilepsy / Q000401:mortality; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D020127:Recovery of Function; D012189:Retrospective Studies; D020521:Stroke / Q000188:drug therapy* / Q000401:mortality*
chemical_list: D001786:Blood Glucose; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
references: N Engl J Med. 2006 Aug 10;355(6):549-59
references: 16899775
references: N Engl J Med. 1996 Oct 3;335(14):1001-9
references: 8801446
references: Stroke. 2002 Dec;33(12):2950-6
references: 12468796
references: Stroke. 2005 Aug;36(8):1627-32
references: 16049199
references: Neurology. 2003 May 13;60(9):1441-6
references: 12743228
references: Crit Care Med. 1995 May;23(5):950-4
references: 7736756
references: Stroke. 1999 Sep;30(9):1969-73
references: 10471452
references: J Neurosurg. 1993 Feb;78(2):188-91
references: 8421201
references: J Neurosurg. 2004 Jul;101(1):104-7
references: 15255259
references: Lancet Neurol. 2007 May;6(5):397-406
references: 17434094
references: J Neurosurg. 2006 Nov;105(5):671-4
references: 17121126
references: Stroke. 2003 Jul;34(7):1717-22
references: 12805488
references: N Engl J Med. 1998 Nov 5;339(19):1349-57
references: 9841303
references: Neurocrit Care. 2004;1(1):53-60
references: 16174898
references: Stroke. 2003 Sep;34(9):2215-20
references: 12907821
references: Stroke. 2006 Jan;37(1):129-33
references: 16322483
references: Stroke. 2001 Apr;32(4):891-7
references: 11283388
references: Stroke. 1999 Jan;30(1):34-9
references: 9880385
references: Circulation. 1998 Mar 31;97(12):1129-35
references: 9537338
references: Stroke. 1999 Apr;30(4):905-15
references: 10187901
references: Lancet. 2002 Jul 6;360(9326):7-22
references: 12114036
references: Acta Radiol Suppl. 1975;346:143-54
references: 782164
references: Stroke. 2003 Jan;34(1):157-63
references: 12511768
references: Neurology. 2004 Sep 28;63(6):1059-64
references: 15452298
references: Ann Neurol. 2003 Jun;53(6):743-51
references: 12783420
references: Stroke. 2001 Apr;32(4):980-6
references: 11283400
references: Lancet. 1996 Oct 19;348(9034):1079-82
references: 8874463
references: Neurology. 2005 Apr 26;64(8):1348-53
references: 15851721
references: Lancet. 1994 Nov 19;344(8934):1383-9
references: 7968073
references: Arch Intern Med. 2004 Apr 26;164(8):880-4
references: 15111374
references: N Engl J Med. 2001 May 10;344(19):1450-60
references: 11346811
references: Neurology. 2003 Nov 25;61(10):1351-6
references: 14638954
references: Stroke. 2000 Oct;31(10):2442-9
references: 11022078
references: Ann Neurol. 1988 Aug;24(2):258-63
references: 3178180
references: Stroke. 2004 Jul;35(7):1744-9
references: 15166393
references: Stroke. 2000 Apr;31(4):841-7
references: 10753985
references: Stroke. 1993 Jul;24(7):987-93
references: 8322400
references: Circulation. 1999 Jan 19;99(2):216-23
references: 9892586
references: Stroke. 2005 Sep;36(9):2024-6
references: 16051891